Companies / Israel
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Teva Focuses On Top Five
September 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Israeli generics firm Teva Pharmaceutical Industries appears to be making significant progress in its efforts to establish a presence in the Romanian generics market, with sales of EUR8mn in the first half of 2008, putting it on course to meet its target of 60% growth for the year. The company aims to gain a position as one of the top three-to-five generic companies in Romania over the next five years through the expansion of its sales force and bringing more of its drugs to the local